Innate immune response to Anaplasma phagocytophilum contributes to hepatic injury

Clinical and Vaccine Immunology

Volumn 13, Issue 7, 2006, Pages 806-809

  Scorpio, Diana G ^a   Von Loewenich, Friederike D ^b   Göbel, Heike ^b   Bogdan, Christian ^b   Dumler, J Stephen ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; MYD88 PROTEIN, HUMAN; MYD88 PROTEIN, MOUSE; MYELOID DIFFERENTIATION FACTOR 88; NOS2 PROTEIN, MOUSE; OXIDOREDUCTASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR NECROSIS FACTOR;

ANAPLASMA PHAGOCYTOPHILUM; ANIMAL; ARTICLE; C3H MOUSE; DISEASE MODEL; EHRLICHIOSIS; ENZYMOLOGY; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; LIVER DISEASE; METABOLISM; MICROBIOLOGY; MOUSE; MOUSE MUTANT; PATHOPHYSIOLOGY; PHAGOCYTE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANAPLASMA PHAGOCYTOPHILUM; ANIMALS; DISEASE MODELS, ANIMAL; EHRLICHIOSIS; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; LIVER DISEASES; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; MICE, SCID; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE SYNTHASE TYPE II; OXIDOREDUCTASES; PHAGOCYTES; TUMOR NECROSIS FACTORS;

EID: 33748035708     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00092-06     Document Type: Article

References (32)

1. Akaike, T., S. Okamoto, T. Sawa, J. Yoshitake, F. Tamura, K. Ichimori, K. Miyazaki, K. Sasamoto, and H. Maeda. 2003. 8-Nitroguanosine formation in viral pneumonia and its implication for pathogenesis. Proc. Natl. Acad. Sci. USA 100:685-690.
2. Akkoyunlu, M., and E. Fikrig. 2000. Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia. Infect. Immun. 68:1827-1833.
3. Akkoyunlu, M., S. E. Malawista, J. Anguita, and E. Fikrig. 2001. Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis. Infect. Immun. 69:5577-5588.
4. Banerjee, R., J. Anguita, D. Roos, and E. Fikrig. 2000. Cutting edge: infection by the agent of human granulocytic ehrlichiosis prevents the respiratory burst by down-regulating gp91phox. J. Immunol. 164:3946-3949.
5. Banerjee, R., J. Anguita, and E. Fikrig. 2000. Granulocytic ehrlichiosis in mice deficient in phagocyte oxidase or inducible nitric oxide synthase. Infect. Immun. 68:4361-4362.
6. Barton, G. M., and R. Medzhitov. 2002. Toll-like receptors and their ligands. Curr. Top. Microbiol. Immunol. 270:81-92.
7. Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2:907-916.
8. Bogdan, C. 2004. Reactive oxygen and reactive nitrogen metabolites as effector molecules against infectious pathogens, p. 357-396. In S. H. E. Kaufmann, R. Medzhitov, and S. Gordon (ed.), The innate immune response to infection. American Society for Microbiology, Washington, D.C.
9. Borjesson, D. L., S. D. Kobayashi, A. R. Whitney, J. M. Voyich, C. M. Argue, and F. R. Deleo. 2005. Insights into pathogen immune evasion mechanisms: Anaplasma phagocytophilum fails to induce an apoptosis differentiation program in human neutrophils. J. Immunol. 174:6364-6372.
10. Brennan, R. E., K. Russell, G. Zhang, and J. E. Samuel. 2004. Both inducible nitric oxide synthase and NADPH oxidase contribute to the control of virulent phase I Coxiella burnetii infections. Infect. Immun. 72:6666-6675.
11. Browning, M., J. W. Garyu, J. S. Dumler, and D. G. Scorpio. 2006. Role of reactive nitrogen species in development of hepatic injury in a C57BL/6 mouse model of human granulocytic anaplasmosis. Comp. Med. 56:55-62.
12. Bunnell, J. E., E. R. Trigiani, S. R. Srinivas, and J. S. Dumler. 1999. Development and distribution of pathologic lesions are related to immune status and tissue deposition of human granulocytic ehrlichiosis agent-infected cells in a murine model system. J. Infect. Dis. 180:546-550.
13. Carlyon, J. A., W. T. Chan, J. Galan, D. Roos, and E. Fikrig. 2002. Repression of rac2 mRNA expression by Anaplasma phagocytophila is essential to the inhibition of superoxide production and bacterial proliferation. J. Immunol. 169:7009-7018.
14. Carlyon, J. A., and E. Fikrig. 2003. Invasion and survival strategies of Anaplasma phagocytophilum. Cell. Microbiol. 5:743-754.
15. Carlyon, J. A., D. Abdel-Latif, M. Pypaert, P. Lacy, and E. Fikrig. 2004. Anaplasma phagocytophilum utilizes multiple host evasion mechanisms to thwart NADPH oxidase-mediated killing during neutrophil infection. Infect. Immun. 72:4772-4783.
16. Cheminay, C., A. Mohlenbrink, and M. Hensel. 2005. Intracellular Salmonella inhibit antigen presentation by dendritic cells. J. Immunol. 174:2892-2899.
17. Choi, K. S., D. G. Scorpio, and J. S. Dumler. 2004. Anaplasma phagocytophilum ligation to toll-like receptor (TLR) 2, but not to TLR4, activates macrophages for nuclear factor-kappa B nuclear translocation. J. Infect. Dis. 189:1921-1925.
18. Espinosa, A., and J. R. Alfano. 2004. Disabling surveillance: bacterial type III secretion system effectors that suppress innate immunity. Cell. Microbiol. 6:1027-1040.
19. Gerke, C., S. Falkow, and Y. H. Chien. 2005. The adaptor molecules LAT and SLP-76 are specifically targeted by Yersinia to inhibit T cell activation. J. Exp. Med. 201:361-371.
20. Hodzic, E., D. Fish, C. M. Maretzki, A. M. De Silva, S. Feng, and S. W. Barthold. 1998. Acquisition and transmission of the agent of human granulocytic ehrlichiosis by Ixodes scapularis ticks. J. Clin. Microbiol. 36:3574-3578.
21. Karupiah, G., J. H. Chen, S. Mahalingam, C. F. Nathan, and J. D. MacMicking. 1998. Rapid interferon gamma-dependent clearance of influenza A virus and protection from consolidating pneumonitis in nitric oxide synthase 2-deficient mice. J. Exp. Med. 188:1541-1546.
22. Lindgren, H., S. Stenmark, W. Chen, A. Tärnvik, and A. Sjöstedt. 2004. Distinct roles of reactive nitrogen and oxygen species to control infection with the facultative intracellular bacterium Francisella tularensis. Infect. Immun. 72:7172-7182.
23. Martin, M. E., J. E. Bunnell, and J. S. Dumler. 2000. Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model. J. Infect. Dis. 181:374-378.
24. Martin, M. E., K. Caspersen, and J. S. Dumler. 2001. Immunopathology and ehrlichial propagation are regulated by interferon-gamma and interleukin-10 in a murine model of human granulocytic ehrlichiosis. Am. J. Pathol. 158:1881-1888.
25. Morgenstern, D. E., M. A. Gifford, L. L. Li, C. M. Doerschuk, and M. C. Dinauer. 1997. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus J. Exp. Med. 185:207-218.
26. Mott, J., Y. Rikihisa, and S. Tsunawaki. 2002. Effects of Anaplasma phagocytophila on NADPH oxidase components in human neutrophils and HL-60 cells. Infect. Immun. 70:1359-1366.
27. Navarro, L., N. M. Alto, and J. E. Dixon. 2005. Functions of the Yersinia effector proteins in inhibiting host immune responses. Curr. Opin. Microbiol. 8:21-27.
28. Pollock, J. D., D. A. Williams, M. A. Gifford, L. L. Li, X. Du, J. Fisherman, S. H. Orkin, C. M. Doerschuk, and M. C. Dinauer. 1995. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9:202-209.
29. Scorpio, D. G., M. Akkoyunlu, E. Fikrig, and J. S. Dumler. 2004. CXCR2 blockade influences Anaplasma phagocytophilum propagation but not histopathology in the mouse model of human granulocytic anaplasmosis. Clin. Diagn. Lab. Immunol. 11:963-968.
30. phox: complement, leukotrienes, and reactive oxidants in acute inflammation. J. Leukoc. Biol. 71:410-416.
31. Takeda, K., T. Kaisho, and S. Akira. 2003. Toll-like receptors. Annu. Rev. Immunol. 21:335-376.
32. von Loewenich, F. D., D. G. Scorpio, U. Reischl, J. S. Dumler, and C. Bogdan. 2004. Frontline: control of Anaplasma phagocytophilum, an obligate intracellular pathogen, in the absence of inducible nitric oxide synthase, phagocyte NADPH oxidase, tumor necrosis factor, Toll-like receptor (TLR)2 and TLR4, or the TLR adaptor molecule MyD88. Eur. J. Immunol. 34:1789-1797.